News

The IND was filed by D-Pharm’s co-development partner in South Korea, Yungjin Pharmaceutical (YJP). YJP gets license to develop, register and market DP-b99 from D-Pharm in South Korea

Botox is indicated as a treatment for urinary incontinence due to detrusor overactivity linked with a neurologic condition like, SCI, MS in adults patients who have an inadequate

In total, the company has recruited 72 patients in the trial and expects to conclude treatment by its stipulated time line. RGN-259, a sterile, preservative-free topical eye drop

EpiPen and EpiPen Jr Auto-Injectors are intended for immediate self administration as emergency supportive therapy only. According to the guidelines given by the National Institute of Allergy and

Millennium offers information and tools to identify and resolve operational cost inefficiencies, patient safety compliance and cash-flow enhancement strategies through its subsidiaries. Millennium president Chris Amandola said they

eClinical Consulting offers services in data safety monitoring, adverse event reporting, statistical analysis, system integration, and study execution. Moreover, eClinical Consulting supports patient recruitment, IRB and study monitoring,

The agreement refers to ‘Azodyl’, a patented, 100% natural, probiotic dietary supplement which is used to reduce azotemia in dogs and cats with moderate to severe renal failure.

Anchen has 27 abbreviated new drug applications (ANDA) pending with the US Food and Drug Administration (FDA). Anchen expects to roll out around 8-10 niche generic products over

The nasal sprays are made from natural, homeopathic ingredients which aid in the relief of allergies and, cold and flu symptoms, claims the company. TheraBiogen CEO Kelly Hickel